Merck Announces Third-quarter 2022 Monetary Outcomes

And hopefully, that will start to get posted far more, but we are focusing on amending the protocol and the dosing regimen below the guidance of the FDA. And I also want to emphasize that we will continue to be committed on the two-month oral. I mean just...